microarray
We, and others, have described a multidrug-resistant phenotype that is associated with cell-cell adhesion or adhesion to extracellular matrices, including fibronectin (Damiano et al., 1999; Green et al., 1999) . The term cell adhesion-mediated drug resistance'' or CAM-DR has been used to describe this phenotype. Molecular mechanisms associated with the CAM-DR phenotype that have been described include alteration in intracellular distribution of the drug target (Hazlehurst et al., 2001) , increased p27 kip1 levels (St Croix et al., 1996; Hazlehurst et al., 2000) , and increased expression of antiapoptotic molecules (Shain et al., 2002) . To further elucidate critical molecules involved in the antiapoptotic signaling environment associated with cell adhesion, we used oligonucleotide microarray analysis to examine gene expression when myeloma cells were placed in suspension culture versus those adhered to fibronectin. Understanding basal levels of gene expression between cells in suspension and those adhered to fibronectin may elucidate why adherent cells are more resistant to drugs and other forms of cellular stress. Indeed, using this analytic approach, we found evidence that activation of nuclear factor-kappa B (NF-kB) is associated with CAM-DR.
Myeloma cells were adhered to fibronectin for 8 h, and the expression profile of 6000 genes compared to that of cells maintained in suspension. mRNA expression levels were determined using Affymetrix HuGeneFL human gene chips, and analysed with GeneChip 3.3 software. Data calculated from hybridization intensities are expressed as an average difference of sequencespecific hybridization (as measured by a perfect complement probe set) and the nonspecific hybridization (as measured by a corresponding 1 base mismatch probe set) following normalization to internal controls. Cells maintained in suspension were designated as the reference population, and genes with altered expression in cells adhered to FN were ranked in numerical order based on fold change. We identified only 53 known gene products induced by twofold or greater following FN adhesion. In contrast, 469 gene products were decreased greater than two fold. Of the 53 genes induced by adhesion to FN, 11 have been documented as regulated by the NF-kB family of transcription factors (Table 1) .
NF-kB was originally identified as a DNA binding complex regulating the expression of genes involved in immune and inflammatory responses (rev. in Gugasyan et al., 2000; Karin and Lin, 2002) . Subsequent studies demonstrated that the NF-kB family includes five members, p50/p105 (NF-kB1), p52/p100 (NF-kB2), cRel, RelB, and p65 (RelA) with a common Rel homology domain (RHD) required for protein dimerization, nuclear translocation and DNA binding. Inactive NF-kB is sequestered in the cytoplasm as inactive complexes with a family of inhibitory proteins called IkB that bind to the RHD and mask the nuclear localization signal. Upon activation by a number of stimuli, the IkB proteins are phosphorylated and targeted for ubiquitination and degradation by the 26S proteasome, allowing NF-kB translocation to the nucleus for the regulation of specific gene expression. The p50/p105 and p52/p100 proteins are synthesized as ankyrin repeat-containing precursors that also function as inhibitory factors. Limited proteolysis of the p105 and p100 proteins by the 26S proteasome is required to generate active DNA binding subunits; however, the specificity of the signal transduction pathway that regulates this limited proteolysis is not entirely understood (Xiao et al., 2001) .
We utilized gel shift analysis to determine if adhesion to fibronectin induces NF-kB binding activity in myeloma cells. As shown in Figure 1a , myeloma cells frequently contain low levels of constitutively active NFkB DNA binding complexes consisting primarily of p50 homodimers as has been previously reported for terminally differentiated B cells (Liou et al., 1994) . Adhesion to fibronectin induces a time-dependent increase in DNA binding activity, reaching a 20-fold increase following 16-24 h of adhesion. The RPMI 8226, ARH77, H929 and MM.1S myeloma cell lines all demonstrate an induction of NF-kB DNA binding activity following adhesion to FN (Figure 1a ). In contrast, the plasma cell leukemia-derived cell line, IM-9, shows only very low affinity for fibronectin binding, and does not display NF-kB activity in FN adhered cells. We believe this may be a reflection of the plasma cell leukemia phenotype, which is found in peripheral circulation, as opposed to the bone marrow microenvironment. Supershift analysis with antibodies specific for NF-kB family members demonstrates the majority of the DNA binding activity in FN adhered cells is composed of RelB/p50 heterodimers with very low levels of p65 ( Figure 1b) . Western blot analysis of nuclear extracts verified the nuclear accumulation of RelB in cells adhered to fibronectin as compared to cells maintained in suspension (Figure 2 ). Activation of NFkB following adhesion to ECM substrates has previously been demonstrated in fibroblasts and smooth muscle cells (Qwarnstrom et al., 1994) , thymic epithelium (Scupoli et al., 2000) , Jurkat T cells (Bearz et al., 1998) and THP-1 monocytic cells (Rosales and Juliano, 1996) . In these diverse cell types, NF-kB activity was associated with translocation of the p50/p65 heterodimer. In contrast, this report is the first to demonstrate adhesion of myeloma cells to fibronectin resulting in the activation of RelB, suggesting a signal-specific regulation of NF-kB activity in these cells.
Reports from other laboratories have demonstrated that adhesion of myeloma cells to bone marrow stromal cells induces the production of TNFa by the myeloma cells and the activation of NF-kB in the stromal cells (Hideshima et al., 2001) . To determine if the NF-kB binding activity induced by the adhesion of 8226 myeloma cells was a secondary effect of TNFa secretion, we compared the DNA binding activity of cells treated with TNFa to those adhered to FN (Figure 3) . In contrast to the NF-kB activity seen following adhesion to FN, TNFa induces a rapid activation of the canonical p65/p50 subunits within 30 min of treatment. Although we cannot entirely rule out the contribution of soluble factors to NF-kB activity in FN adhered cells, we did not find increases in TNFa mRNA in our system, nor was the NF-kB DNA binding profile compatible with induction by TNFa. Therefore, these data demonstrate that RelB activation by adhesion to FN is not secondary to TNFa secretion. The mechanism of differential NFkB activation in myeloma cells, and the point of bifurcation in this pathway is not currently known. However, previous reports have demonstrated constitutive RelB activation in v-src transformed fibroblasts (Shain et al., 1999) suggesting a role for the protooncogene c-src, or a src family member contributing to adhesion-mediated NF-kB activity in myeloma cells.
Over 150 target genes have been identified as regulated by the NF-kB family. In the hematopoietic system, NF-kB is considered a central regulator of inflammation and the immune response, primarily because of the large number of cytokines and growth factors whose expression is under NF-kB control (Gugasyan et al., 2000) . Recent studies have implicated NF-kB-mediated gene expression in mechanisms of resistance to apoptosis induced by both physiological and cytotoxic stimuli (Wang et al., 1996; Van Antwerp et al., 1996; Feinman et al., 1999; Bian et al., 2001) . Although distinct mechanisms of activation have been described, both cytotoxic drugs and death receptors initiate the proteolytic caspase cascade that cleaves essential cell proteins. Caspase activity is regulated at multiple points by proteins that are transcriptional products of NF-kB including Bfl-1/A1 (Zong et al., 1999; Wang et al., 1999a; Grumont et al., 1999) , Flice inhibitory protein (Micheau et al., 2001) , Bcl-x L , and the inhibitor of apoptosis (IAP) family (Chu et al., 1997; Wang et al., 1998) . Microarray analysis demonstrated a 2.1-fold induction of c-IAP mRNA in myeloma cells adhered to FN for 8 h (see Table 1 ). We further examined the mRNA and protein expression of c-IAP2 in myeloma cells adhered to FN. (Damiano et al., 1999) . Myeloma cell lines 8226, ARH77, H929, IM-9, and MM.1S were adhered to FN for 16 h, nuclear extracts were prepared as previously described (Catlett-Falcone et al., 1999) and assayed for DNA binding activity using a radiolabeled probe corresponding to the NF-kB consensus sequence (Shain et al., 1999) . S: Cells maintained in suspension; FN: Cells adhered to fibronectin. (b). NF-kB activity in FN-adhered myeloma cells is primarily RelB/p50 heterodimers. To identify NF-kB subunits, nuclear extracts prepared as described were incubated with Rel-specific antibodies for 60 m on ice prior to EMSA analysis. All antibodies were obtained from Santa Cruz Biotech (Santa Cruz, CA, USA) . The IAP proteins have been shown to bind and potently inhibit procaspase 9, preventing activation of the effector caspases 3, 6, and 7 through the mitochondrial pathway. In addition, c-IAP1, c-IAP2, and XIAP can complex with the active form of caspases 3 and 7, suppressing amplification of death receptor-mediated apoptosis through caspase 8. Thus, induced expression of c-IAP protein by adhesion to fibronectin may contribute to resistance to both physiological-and cytotoxic-induced apoptosis in this phenotype. Further studies are warranted to identify the role of the c-IAP family in the CAM-DR phenotype. Expression of the antiapoptotic family member, Bcl-x L has been reported to be regulated by c-Rel and p65 transactivation in HT 1080 sarcoma cells . Additionally, RelB DNA binding activity has recently been implicated in the survival of B lymphocytes following ligation of the TNF family receptor TACI/BCMA/BAFF-R (Do et al., 2000; Do RK and Chen-Kiang, 2002) . This activity was associated with increased expression of the antiapoptotic proteins, Bcl-2 and Bcl-xL, and reduced expression of the proapoptotic factor, Bak. However, in agreement with our previous report demonstrating no changes in the expression levels of the Bcl-2 family following adhesion to FN (Damiano et al., 1999) , Bcl-x L expression was not induced by FN adhesion in our myeloma system. Although the mechanism of selectivity is not clear, these data support a differential regulation of gene expression by microenvironmental factors in physiological systems.
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Microarray technology can be used to provide a global view of gene expression that defines a specific phenotype (Kudoh et al., 2000) . Using this approach, we have identified a signal transduction pathway activated by the interaction of tumor cells with their microenvironment. Several of the NF-kB gene products identified by microarray analysis in our study are well-characterized survival factors in multiple myeloma. Although it is tempting to propose any one of these gene products, 'the CAM-DR resistance factor', it is unlikely that the microenvironment conferred resistant phenotype is entirely because of a single gene product. Rather, the antiapoptotic phenotype conferred by the microenvironment is likely to reflect a culmination of the gene expression profile, and is likely to involve additional transcriptional regulation in addition to RelB. Identification of the NF-kB signal transduction pathway by the gene expression profile supports the hypothesis that this pathway may represent a novel molecular target for drug development (Van Antwerp et al., 1996; Wang et al., 1999b; Mayo and Baldwin, 2000) . Further investigation identifying the specificity of RelB activation by the microenvironment may provide additional targets for chemotherapeutic intervention. Adhesion of FN activates RelB in myeloma cells TH Landowski et al
